Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now — Positive

KGC  PAAS   Zacks Investment Research — February 10, 2025

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

image for news Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now

Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows — Neutral

NVO   Seeking Alpha — February 10, 2025

Novo Nordisk's drastic selloff may be attributed to the management overpromising CagriSema's 25% weight loss target along with the decelerating top-line growth trend. The company now faces numerous headwinds from the Centers for Medicare and Medicaid Services, GLP1 compounders, and new biotech companies. Even so, we believe that the correction has been overly done, with NVO now trading way below its 10Y P/E means and its direct competitors.

image for news Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows

Analysts revise Amazon stock price targets after earnings — Positive

AMZN   Finbold — February 10, 2025

Amazon's (NASDAQ: AMZN) Q4 and FY 2024 earnings report, released on February 6, was a double beat. Even though both earnings per share (EPS) and revenue came in above estimates, the markets weren't exactly satisfied.

image for news Analysts revise Amazon stock price targets after earnings

Schwab is buying back a chunk of its stock as TD sells its 10% stake — Neutral

SCHW   Market Watch — February 10, 2025

Even after buying the $1.5 billion in stock, Schwab will still have $7.2 billion remaining under its existing stock-buyback program.

image for news Schwab is buying back a chunk of its stock as TD sells its 10% stake

E. Coli Outbreak Holds Back McDonald's Earnings — Negative

MCD   Bloomberg Markets and Finance — February 10, 2025

McDonald's global same-store sales climbed 0.4% in the fourth quarter, despite a drop of 1.4% in the US. An E. coli outbreak in the US scared customers away halting some momentum.

image for news E. Coli Outbreak Holds Back McDonald's Earnings

ON Semiconductor Corp. (ON) Misses Q4 Earnings and Revenue Estimates — Negative

ON   Zacks Investment Research — February 10, 2025

ON Semiconductor Corp. (ON) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.25 per share a year ago.

image for news ON Semiconductor Corp. (ON) Misses Q4 Earnings and Revenue Estimates

Intel: It's Time To Let Go — Negative

INTC   Seeking Alpha — February 10, 2025

Intel has lost 65% in value since 2021 and has suspended its dividend. Intel's core x86 CPU business is losing market share to AMD, while Intel's gross margin is also far behind its peers. Intel's new leadership faces urgent decisions to avoid falling further behind competitors like AMD, NVIDIA, and TSMC in key growth markets.

image for news Intel: It's Time To Let Go

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128404&wire=1 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)

Is Costco Wholesale Stock a Buy, Sell, or Hold in 2025? — Positive

COST   The Motley Fool — February 10, 2025

Bulk-buying, bargain-hunting shoppers propelled Costco Wholesale (COST -0.57%) to a record-breaking 2024 for sales and earnings. The discount retailer is benefiting from a resilient economic backdrop while capitalizing on an ongoing e-commerce expansion.

image for news Is Costco Wholesale Stock a Buy, Sell, or Hold in 2025?

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Dimitris Moraitis as Vice President of Strategy & Operations. Mr. Moraitis brings over 25 years of experience in strategic planning, operations, and business development within the pharmaceutical sector.

image for news Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

RADNOR, PA / ACCESS Newswire / February 10, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ:CROX) ("Crocs" or the "Company") on behalf of investors who purchased or otherwise acquired Crocs common stock between November 3, 2022, and October, 28 2024, inclusive (the "Class Period"). This action, captioned Carretta v.

image for news Lead Plaintiff Deadline Approaching in CROX: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Against Crocs, Inc.

3 Reasons to Love This Underperforming Chipmaker — Neutral

QCOM   MarketBeat — February 10, 2025

Shares of tech giant Qualcomm Inc. NASDAQ: QCOM have been stuck in a holding pattern for months, but recent signs point to a shift in momentum. After a largely sideways trend since July, the stock has gained 10% since December.

image for news 3 Reasons to Love This Underperforming Chipmaker

Take-Two Interactive chairman and CEO Strauss Zelnick joins 'Squawk Box' to discuss the company's quarterly earnings results, state of gaming, gaming release pipeline, regulatory and M&A outlook under the new Trump administration, latest news on Grand Theft Auto VI, impact of AI on gaming, and more.

image for news Take-Two Interactive CEO Strauss Zelnick on Grand Theft Auto VI: We couldn't be more excited

The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities. The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities.

image for news Walmart Grocery Market Share to Increase with Rising Demand for Digital Shopping and Value-Oriented Options

2 Stocks to Shield Your Portfolio from AI and Tech Froth — Neutral

PM  XOM   MarketBeat — February 10, 2025

In the current state of the stock market, investors argue over whether valuations are too high. Some see historical indicators as signs of doom, while others feel that future earnings will justify prices.

image for news 2 Stocks to Shield Your Portfolio from AI and Tech Froth

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Joint Stock Company Kaspi.kz ("Kaspi.kz" or "the Company") (NASDAQ:KSPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Kaspi.kz securities between January 19, 2024 and September 19, 2024, both dates inclusive (the "Class Period").

image for news KSPI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Joint Stock Company Kaspi.kz Investors Have Opportunity to Lead Class Action Lawsuit!

Hydrofarm Announces Reverse Stock Split — Neutral

HYFM   GlobeNewsWire — February 10, 2025

SHOEMAKERSVILLE, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) (“Hydrofarm” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, par value $0.0001, which will be effective at 5:00 pm Eastern Time on February 12, 2025. The Company's common stock will continue to be traded on The Nasdaq Capital Market on a split-adjusted basis beginning on February 13, 2025, under the Company's existing trading symbol “HYFM.”

image for news Hydrofarm Announces Reverse Stock Split

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer — Neutral

IOVA   GlobeNewsWire — February 10, 2025

SAN CARLOS, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that Dan Kirby will join the Company's executive leadership team in the newly created role of Chief Commercial Officer, effective today.

image for news Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

Glass Lewis Finds Matthews Has "Persistently Deteriorated and Consistently Underperformed During Substantially All Measurement Periods, Including During the Fullness of Mr. Bartolacci's Tenure as CEO" Asserts Barington "Has Offered Investors a Reasonable, Credible and Incremental Slate of Candidates" and a "More Promising Roadmap" for the Company Recommends Shareholders Vote "WITHHOLD" on Matthews' Nominees Terry L.

image for news Leading Proxy Advisory Firm Glass Lewis Joins ISS and Egan-Jones in Recommending Matthews International Shareholders Vote the GOLD Proxy Card "FOR" ALL of Barington Capital's Nominees: Ana Amicarella, Chan Galbato and James Mitarotonda

McDONALD'S REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS — Neutral

MCD   PRNewsWire — February 10, 2025

Global Systemwide sales* were over $130 billion for the full year, with full year growth of more than $1 billion (more than $2 billion in constant currencies) Systemwide sales to loyalty members were approximately $30 billion for the full year and approximately $8 billion for the quarter across 60 loyalty markets, with full year growth of 30% over prior year 90-day active loyalty users were over 175 million across 60 loyalty markets as of year-end, with growth of approximately 15% over prior year CHICAGO , Feb. 10, 2025 /PRNewswire/ -- McDonald's Corporation today announced results for the fourth quarter and …

image for news McDONALD'S REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS